These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33941763)

  • 1. A drug-repositioning screen using splicing-sensitive fluorescent reporters identifies novel modulators of VEGF-A splicing with anti-angiogenic properties.
    Star E; Stevens M; Gooding C; Smith CWJ; Li L; Ayine ML; Harper SJ; Bates DO; Oltean S
    Oncogenesis; 2021 May; 10(5):36. PubMed ID: 33941763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The VEGF-A exon 8 splicing-sensitive fluorescent reporter mouse is a novel tool to assess the effects of splicing regulatory compounds
    Stevens M; Star E; Lee M; Innes E; Li L; Bowler E; Harper S; Bates DO; Oltean S
    RNA Biol; 2019 Dec; 16(12):1672-1681. PubMed ID: 31432737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis.
    Nowak DG; Amin EM; Rennel ES; Hoareau-Aveilla C; Gammons M; Damodoran G; Hagiwara M; Harper SJ; Woolard J; Ladomery MR; Bates DO
    J Biol Chem; 2010 Feb; 285(8):5532-40. PubMed ID: 19906640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors.
    Nowak DG; Woolard J; Amin EM; Konopatskaya O; Saleem MA; Churchill AJ; Ladomery MR; Harper SJ; Bates DO
    J Cell Sci; 2008 Oct; 121(Pt 20):3487-95. PubMed ID: 18843117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of VEGF-A Alternative Splicing as a Novel Treatment in Chronic Kidney Disease.
    Stevens M; Oltean S
    Genes (Basel); 2018 Feb; 9(2):. PubMed ID: 29462869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-angiogenic isoforms of VEGF in health and disease.
    Qiu Y; Hoareau-Aveilla C; Oltean S; Harper SJ; Bates DO
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1207-13. PubMed ID: 19909248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of Receptor Tyrosine Kinase Activity through Alternative Splicing of Ligands and Receptors in the VEGF-A/VEGFR Axis.
    Stevens M; Oltean S
    Cells; 2019 Mar; 8(4):. PubMed ID: 30925751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia.
    Hulse RP; Beazley-Long N; Hua J; Kennedy H; Prager J; Bevan H; Qiu Y; Fernandes ES; Gammons MV; Ballmer-Hofer K; Gittenberger de Groot AC; Churchill AJ; Harper SJ; Brain SD; Bates DO; Donaldson LF
    Neurobiol Dis; 2014 Nov; 71():245-59. PubMed ID: 25151644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The alternatively spliced anti-angiogenic family of VEGF isoforms VEGFxxxb in human kidney development.
    Bevan HS; van den Akker NM; Qiu Y; Polman JA; Foster RR; Yem J; Nishikawa A; Satchell SC; Harper SJ; Gittenberger-de Groot AC; Bates DO
    Nephron Physiol; 2008; 110(4):p57-67. PubMed ID: 19039247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splicing factor polymorphisms, the control of VEGF isoforms and association with angiogenic eye disease.
    Carter JG; Cherry J; Williams K; Turner S; Bates DO; Churchill AJ
    Curr Eye Res; 2011 Apr; 36(4):328-35. PubMed ID: 21309690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of VEGF-A splice variant mRNA expression with outcome in bevacizumab-treated patients with metastatic breast cancer.
    Pentheroudakis G; Kotoula V; Kouvatseas G; Charalambous E; Dionysopoulos D; Zagouri F; Koutras A; Papazisis K; Pectasides D; Samantas E; Dimopoulos MA; Papandreou CN; Fountzilas G
    Clin Breast Cancer; 2014 Oct; 14(5):330-8. PubMed ID: 24703319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balance of pro- versus anti-angiogenic splice isoforms of vascular endothelial growth factor as a regulator of neuroblastoma growth.
    Peiris-Pagès M; Harper SJ; Bates DO; Ramani P
    J Pathol; 2010 Oct; 222(2):138-47. PubMed ID: 20662003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF Splicing and the Role of VEGF Splice Variants: From Physiological-Pathological Conditions to Specific Pre-mRNA Splicing.
    Guyot M; Pagès G
    Methods Mol Biol; 2015; 1332():3-23. PubMed ID: 26285742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of an exonic splicing silencer in exon 6A of the human VEGF gene.
    Wang R; Crystal RG; Hackett NR
    BMC Mol Biol; 2009 Nov; 10():103. PubMed ID: 19922608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two Novel Heparin-binding Vascular Endothelial Growth Factor Splices, L-VEGF144 and L-VEGF138, are Expressed in Human Glioblastoma Cells.
    Shen CC; Cheng WY; Chiao MT; Liang YJ; Mao TF; Liu BS
    Curr Neurovasc Res; 2016; 13(3):207-18. PubMed ID: 27220431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IRAS: High-Throughput Identification of Novel Alternative Splicing Regulators.
    Zheng S
    Methods Enzymol; 2016; 572():269-89. PubMed ID: 27241759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice.
    Rennel E; Waine E; Guan H; Schüler Y; Leenders W; Woolard J; Sugiono M; Gillatt D; Kleinerman E; Bates D; Harper S
    Br J Cancer; 2008 Apr; 98(7):1250-7. PubMed ID: 18349828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SRPK1 inhibition in vivo: modulation of VEGF splicing and potential treatment for multiple diseases.
    Oltean S; Gammons M; Hulse R; Hamdollah-Zadeh M; Mavrou A; Donaldson L; Salmon AH; Harper SJ; Ladomery MR; Bates DO
    Biochem Soc Trans; 2012 Aug; 40(4):831-5. PubMed ID: 22817743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A broadly applicable high-throughput screening strategy identifies new regulators of Dlg4 (Psd-95) alternative splicing.
    Zheng S; Damoiseaux R; Chen L; Black DL
    Genome Res; 2013 Jun; 23(6):998-1007. PubMed ID: 23636947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of RNA-binding proteins that regulate FGFR2 splicing through the use of sensitive and specific dual color fluorescence minigene assays.
    Newman EA; Muh SJ; Hovhannisyan RH; Warzecha CC; Jones RB; McKeehan WL; Carstens RP
    RNA; 2006 Jun; 12(6):1129-41. PubMed ID: 16603716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.